<SEC-DOCUMENT>0001193125-19-226895-index.html : 20190822
<SEC-HEADER>0001193125-19-226895.hdr.sgml : 20190822
<ACCEPTANCE-DATETIME>20190822162232
ACCESSION NUMBER:		0001193125-19-226895
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20190822
DATE AS OF CHANGE:		20190822
GROUP MEMBERS:		BCIP LIFE SCIENCES ASSOCIATES, LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-80035
		FILM NUMBER:		191046327

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bain Capital Life Sciences Fund, L.P.
		CENTRAL INDEX KEY:			0001687968
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-516-2000

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>d64544dsc13d.htm
<DESCRIPTION>SC 13D
<TEXT>
Document 1 - file: d64544dsc13d.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>d64544dex99a.htm
<DESCRIPTION>EX-99.A
<TEXT>
Document 2 - file: d64544dex99a.htm

</DOCUMENT>
</SEC-DOCUMENT>